Self-reported beta-lactam allergy, mislabeling and inappropriate antibiotic use: a study from South India

2025/01/01 by Krishna Suresh, Vettakkara Kandy Muhammed Niyas, Sabeer Hameed +2 · 1 voice
Medicine · #Drug-Induced Adverse Reactions #Allergic Rhinitis and Sensitization #Food Allergy and Anaphylaxis Research

paper · pdf · doi:10.1017/ash.2025.10049

openalex publication_date 2025/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/21

Abstract

This study assessed beta-lactam allergy labels in 300 hospitalized adults using validated scores. Over 50% with penicillin and 21% with cephalosporin allergies were classified as low risk. Among those receiving alternative antibiotics due to inappropriate allergy labels, 44% were low-risk. Findings support structured allergy delabeling programs to enhance antimicrobial stewardship.

Citations

• Development and validation of a cephalosporin allergy clinical decision rule

Discussions

• Self-reported beta-lactam allergy, mislabeling and inappropriate antibiotic use: a study from South India--Nearly half of patients were candidates for delabeling, highlighting the need for structured [bsky, 2 points, 0 comments]

Related

• Antibiotic use and financial impact of a comprehensive beta-lactam allergy management program
• Point prevalence survey of antibiotic allergies in hospitalized patients
• A rapid literature review of the impact of penicillin allergy on antibiotic resistance
• Penicillin allergy de-labelling implementation intervention in a UK hospital: a process evaluation, the patient experience
• Direct oral amoxicillin challenge in a tertiary care center: validating PEN-FAST in inpatient and outpatient populations with low-risk penicillin allergies